| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial.
|
Lancet Oncol
|
2010
|
3.30
|
|
2
|
Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma.
|
Clin Cancer Res
|
2003
|
2.28
|
|
3
|
Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study.
|
J Clin Oncol
|
2009
|
1.90
|
|
4
|
Expressed wishes and incidence of euthanasia in advanced lung cancer patients.
|
Eur Respir J
|
2012
|
1.46
|
|
5
|
Validation of computational fluid dynamics in CT-based airway models with SPECT/CT.
|
Radiology
|
2010
|
1.27
|
|
6
|
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.
|
Am J Respir Crit Care Med
|
2010
|
1.14
|
|
7
|
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer.
|
Lung Cancer
|
2009
|
1.11
|
|
8
|
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma.
|
J Thorac Oncol
|
2011
|
1.00
|
|
9
|
Preferred and actual involvement of advanced lung cancer patients and their families in end-of-life decision making: a multicenter study in 13 hospitals in Flanders, Belgium.
|
J Pain Symptom Manage
|
2011
|
0.90
|
|
10
|
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor.
|
Chest
|
2011
|
0.90
|
|
11
|
Are patients' preferences for information and participation in medical decision-making being met? Interview study with lung cancer patients.
|
Palliat Med
|
2010
|
0.88
|
|
12
|
Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study.
|
J Thorac Oncol
|
2011
|
0.86
|
|
13
|
Postextubation obstructive pseudomembranes: a case series and review of a rare complication after endotracheal intubation.
|
Lung
|
2010
|
0.86
|
|
14
|
Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy.
|
Eur J Cardiothorac Surg
|
2006
|
0.84
|
|
15
|
Preferences of patients with advanced lung cancer regarding the involvement of family and others in medical decision-making.
|
J Palliat Med
|
2010
|
0.80
|
|
16
|
Rapid-onset adult respiratory distress syndrome after activated charcoal aspiration. A pitch-black tale of a potential to kill.
|
Am J Respir Crit Care Med
|
2015
|
0.76
|
|
17
|
Malignant pleural mesothelioma with heterologous osteoblastic elements: computed tomography, magnetic resonance, and positron emission tomography imaging characteristics of a rare tumor.
|
J Comput Assist Tomogr
|
2005
|
0.75
|